|
|
|
Proper diagnosis is the first step toward
relief. |
|
| |
Dry eye is one of the most
under-diagnosed ocular diseases, and yet it is the most common reason
why patients go see their eye care professional.
Dry eye is a
multifactorial disease of the tears and ocular surface that results in
symptoms of discomfort, visual disturbance, and tear film instability
with potential damage to the ocular surface. It is accompanied by
increased osmolarity of the tear film and inflammation of the ocular
surface.
Osmolarity
In fact, dry eye disease
occurs when your eyes do not produce enough tears or produce poor
quality tears. That's why it's essential you get your tears analyzed by
your eye doctor. Only an eye doctor can properly diagnose your problem
and treat it appropriately.
We will take a sample of tears from
each eye and use the TearLab device to measure osmolarity (the saltiness
of your tears). As osmolarity in your tears increase ocular surface
cells become damaged. Your doctor will need an amount of tear fluid no
larger than the period at the end of this sentence.
|
|
| |
 |
 |
A precise and predictive point-of-care diagnostic
test |
The TearLab
Osmolarity System is intended to measure the osmolarity of human
tears to aid in the diagnosis of dry eye disease in patients
suspected of having dry eye disease, in conjunction with other
methods of clinical evaluation. We use the TearLab osmolarity
data to inform you of your treatment plan based on disease
severity and we manage your progress by evaluating therapeutic
effectiveness.
TearLab is pioneering the future of tear
film diagnostics to elevate patient care. Using its first of a
kind point-of-care ophthalmic in vitro diagnostic platform,
TearLab allows us to add data to your insights to guide the
diagnosis and management of the ocular surface. With precise and
predictive information available in a matter of seconds, we are
able to evaluate tear film health, uncover abnormal osmolarity
and inform your treatment plan based on severity, and manage
your progress. |
|
| |
 |
Features In-depth Tear Film analysis |
The CA-800,
Topcon's corneal analyzer, enhances the diagnosis for dry eye
patients with the new Tear Film analysis. The CA-800 is a
placido-based topography system that delivers accurate, high
resolution images of the anterior corneal surface. The latest
features of the CA-800 includes an enhanced meibography
observation and a comprehensive analysis of the Tear Film by
using the Blink Detection and Tear Breakup Time measuring modes.
Blink Detection
The Blink Detection
automatically detects blinks and calculates the average blinks
per minute and blinks interval. The analysis of the Blink
Detection includes the average Inter-Blink Interval (IBI
average) that is used to calculate the Ocular Protection Index
(OPI), the IBI standard deviation, the total duration of the
time range analysed and the average number of blinks per minute. |
 |
| |
|
Tear Breakup Time
The Tear Breakup Time (TBT) records the patients tear film
condition while they hold their blink and calculates the time of
first breakup and average time for breakup of the Tear Film.
This new feature allows video playback with a coloured
overlay to show the quality of the corneal surface. The sectors
will be color-coded from green to red according to the scale on
the left side of the image, showing the breakup overtime of the
Tear Film. |
 |
| |
|
Enhanced meibography
observation
With the infra-red illumination of the
CA-800, the Meibomian Glands of the upper and lower eyelid can
be captured and analysed. Now two types of adjustable Contrast
Enhancement are displayed directly below the image to enhance
the Meibomian Gland viewing.
The Soft Contrast
Enhancement is a more subtle contrast adjustment and makes the
dark areas of the image darker, while the Hard Contrast
Enhancement is a more dynamic contrast adjustment that brings
more detail to the image for improved observation capability. |
 |
|
| |
 |
InflammaDry
is the first and only, rapid result, in-office test that detects
elevated levels of MMP-9, an inflammatory marker that is consistently
elevated in the tears of patients with dry eye disease. Using a simple
4-step process, InflammaDry recognizes elevated levels of MMP-9, to
identify patients that may otherwise be missed with other dry eye
testing methods.
With InflammaDry we can:
• Make a rapid,
accurate diagnosis at the point-of-care
• Reduce
complications associated with dry eye
• Help improve clinical
outcomes and your quality of life
• Identify and treat dry eye
disease prior to surgery for better post-operative outcomes |
| Using direct sampling microfiltration technology,
InflammaDry accurately identifies elevated levels of MMP-9 protein in
tear fluid samples taken from the inside lining of the lower eyelid, the
palpebral conjunctiva. Using the four simple steps, InflammaDry
test results are achieved in just 10 minutes, aiding in the diagnosis of
dry eye before you leave the office. |
| |
| |
| |
 |
|
With Ampleye Scleral GP (Gas
Permeable) contact Lenses, there is no corneal involvement, so irregular
cornea fitting is simplified and your comfort is unequaled.
|
Ampleye is an excellent option for patients with:
• Irregular corneas
• Lens stability issues
• Corneal GP intolerance
• Patients with dry eye conditions
• Patients
with ocular surface disease
PLUS:
Ampleye is FDA indicated for therapeutic use and the safe and effective
management of ocular surface disease and dry eye complications. |
 |
|
|
|